Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06466291

Spanish Wilson Disease Registry

The main objective and purpose of the Registry is to know the current status of Wilson Disease in Spain.

As secondary objectives, the prevalence and incidence of the disease will be analysed.

Likewise, the analysis aims to define future areas of interest in its pathogenesis, diagnosis, natural history, follow-up, prognosis and treatment.

Improving knowledge at a national level can help to design screening strategies and improve diagnostic circuits.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Wilson Disease Basal Ganglia Diseases Brain Diseases Brain Diseases, Metabolic Brain Diseases, Metabolic, Inborn Central Nervous System Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Digestive System Diseases Genetic Diseases, Inborn Hepatolenticular Degeneration Heredodegenerative Disorders, Nervous System Liver Diseases Metabolic Diseases Metabolism, Inborn Errors Metal Metabolism, Inborn Errors Movement Disorders Nervous System Diseases Neurodegenerative Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Clinic

Barcelona, 08036, Spain

Location status: Recruiting

Location contact

Zoe Mariño

CONTACT

About this study

Retrospective and prospective study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with a confirmed Wilson Disease diagnosis

Exclusion criteria

  • Refusal to sign the informed consent for the study

Treatment and study plan

Primary outcomes

  1. To know the current status of Wilson Disease in Spain

    Time frame: 2025

Secondary outcomes

  1. To analyse the prevalence of Wilson Disease in Spain

    Time frame: 2025

  2. To analyse the incidence of Wilson Disease in Spain

    Time frame: 2025

Other outcomes

  1. To define future areas of interest in Wilson Disease

    Time frame: 2025

    To define future areas of interest in the disease pathogenesis, diagnosis, natural history, follow-up, prognosis and treatment

Study contacts

Contact information is provided by the study sponsor or research team.

Asociación Española para el Estudio del Hígado Asociación Española para el Estudio del Hígado

CONTACT

[email protected]

0034915551119

Sponsors and collaborators

Lead sponsor

Asociación Española para el Estudio del Hígado

Other

Registry information

Official study title

Registro de Enfermedad de Wilson en España

Important dates

Study start
2021
Primary completion
2030
Study completion
2030
First posted
Jun 20, 2024
Registry last updated
Jun 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.